A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases

Background: Although rare bone diseases (RBDs) present mobility challenges, there is little consolidated evidence on evaluated mobility measurement tools or how mobility impairments impact daily activities and quality of life (QoL). Objectives and design: This systematic literature review investigat...

Full description

Saved in:
Bibliographic Details
Main Authors: Inês Alves, Ingunn Westerheim, Edward C. Hsiao, Jaymin Upadhyay, Luca Sangiorgi, Alexander Artyomenko, Kim Croskery, Juliet Johns, Emma Warnants, Gabor Barton
Format: Article
Language:English
Published: SAGE Publishing 2025-08-01
Series:Therapeutic Advances in Musculoskeletal Disease
Online Access:https://doi.org/10.1177/1759720X251369963
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849230186657087488
author Inês Alves
Ingunn Westerheim
Edward C. Hsiao
Jaymin Upadhyay
Luca Sangiorgi
Alexander Artyomenko
Kim Croskery
Juliet Johns
Emma Warnants
Gabor Barton
author_facet Inês Alves
Ingunn Westerheim
Edward C. Hsiao
Jaymin Upadhyay
Luca Sangiorgi
Alexander Artyomenko
Kim Croskery
Juliet Johns
Emma Warnants
Gabor Barton
author_sort Inês Alves
collection DOAJ
description Background: Although rare bone diseases (RBDs) present mobility challenges, there is little consolidated evidence on evaluated mobility measurement tools or how mobility impairments impact daily activities and quality of life (QoL). Objectives and design: This systematic literature review investigated: (1) the impacts of mobility impairment on daily activities/QoL; (2) the suitability/comprehensiveness of tools measuring mobility. Data sources and methods: MEDLINE/Embase databases (January 19, 2022) and Google (October 19, 2022) were searched for articles published between 2011 and 2022; conference proceedings from 2020 to 2021 were hand-searched. Included articles reported on how mobility impairments impact daily activities/QoL, or the use of tools for measuring mobility, in RBDs. A narrative analysis using descriptive statistics was conducted. Studies were assessed for risk of bias using The Alberta Heritage Foundation for Medical Research Quality Assessment Criteria and National Institute of Health Quality Assessment Tool for Case Series Studies. Results: Inclusion criteria were met by 113 articles, investigating 39 RBDs (sample sizes: N  = 1–959). Mobility impairments, commonly joint function/gait disturbances, negatively impacted daily activities ( n  = 47 cohorts; frequently walking (27/47; 57.4%)) and QoL ( n  = 36 cohorts; commonly pain (30/36; 83.3%; Objective 1). There were 34 functional assessments, 22 questionnaires, and 5 technologies described. Only nine functional assessments/questionnaires were reported to have good validity/reliability/responsiveness for an RBD (not reported for technologies); none comprehensively captured daily living/QoL impacts of mobility impairment. The quality of studies was moderate, though many were case studies/series, which are at inherent risk of bias. Conclusion: Few tools comprehensively captured mobility impairments and associated impacts on daily activities/QoL. Consistent reporting of tools’ validity/reliability/responsiveness would support clinicians in selecting methods for use across RBD populations. Used remotely, wearables could support understanding of real-world mobility challenges. Since searches were conducted, additional technologies (e.g., remote gait analysis) have been tested in RBDs, although validation is required. Protocol PROSPERO registration: CRD42022311513. Sponsored by Ipsen.
format Article
id doaj-art-bbf5aea89818413a8bc3f4ec41d265f1
institution Kabale University
issn 1759-7218
language English
publishDate 2025-08-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Musculoskeletal Disease
spelling doaj-art-bbf5aea89818413a8bc3f4ec41d265f12025-08-21T10:03:20ZengSAGE PublishingTherapeutic Advances in Musculoskeletal Disease1759-72182025-08-011710.1177/1759720X251369963A systematic literature review of the impact and measurement of mobility impairment in rare bone diseasesInês AlvesIngunn WesterheimEdward C. HsiaoJaymin UpadhyayLuca SangiorgiAlexander ArtyomenkoKim CroskeryJuliet JohnsEmma WarnantsGabor BartonBackground: Although rare bone diseases (RBDs) present mobility challenges, there is little consolidated evidence on evaluated mobility measurement tools or how mobility impairments impact daily activities and quality of life (QoL). Objectives and design: This systematic literature review investigated: (1) the impacts of mobility impairment on daily activities/QoL; (2) the suitability/comprehensiveness of tools measuring mobility. Data sources and methods: MEDLINE/Embase databases (January 19, 2022) and Google (October 19, 2022) were searched for articles published between 2011 and 2022; conference proceedings from 2020 to 2021 were hand-searched. Included articles reported on how mobility impairments impact daily activities/QoL, or the use of tools for measuring mobility, in RBDs. A narrative analysis using descriptive statistics was conducted. Studies were assessed for risk of bias using The Alberta Heritage Foundation for Medical Research Quality Assessment Criteria and National Institute of Health Quality Assessment Tool for Case Series Studies. Results: Inclusion criteria were met by 113 articles, investigating 39 RBDs (sample sizes: N  = 1–959). Mobility impairments, commonly joint function/gait disturbances, negatively impacted daily activities ( n  = 47 cohorts; frequently walking (27/47; 57.4%)) and QoL ( n  = 36 cohorts; commonly pain (30/36; 83.3%; Objective 1). There were 34 functional assessments, 22 questionnaires, and 5 technologies described. Only nine functional assessments/questionnaires were reported to have good validity/reliability/responsiveness for an RBD (not reported for technologies); none comprehensively captured daily living/QoL impacts of mobility impairment. The quality of studies was moderate, though many were case studies/series, which are at inherent risk of bias. Conclusion: Few tools comprehensively captured mobility impairments and associated impacts on daily activities/QoL. Consistent reporting of tools’ validity/reliability/responsiveness would support clinicians in selecting methods for use across RBD populations. Used remotely, wearables could support understanding of real-world mobility challenges. Since searches were conducted, additional technologies (e.g., remote gait analysis) have been tested in RBDs, although validation is required. Protocol PROSPERO registration: CRD42022311513. Sponsored by Ipsen.https://doi.org/10.1177/1759720X251369963
spellingShingle Inês Alves
Ingunn Westerheim
Edward C. Hsiao
Jaymin Upadhyay
Luca Sangiorgi
Alexander Artyomenko
Kim Croskery
Juliet Johns
Emma Warnants
Gabor Barton
A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases
Therapeutic Advances in Musculoskeletal Disease
title A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases
title_full A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases
title_fullStr A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases
title_full_unstemmed A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases
title_short A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases
title_sort systematic literature review of the impact and measurement of mobility impairment in rare bone diseases
url https://doi.org/10.1177/1759720X251369963
work_keys_str_mv AT inesalves asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT ingunnwesterheim asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT edwardchsiao asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT jayminupadhyay asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT lucasangiorgi asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT alexanderartyomenko asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT kimcroskery asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT julietjohns asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT emmawarnants asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT gaborbarton asystematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT inesalves systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT ingunnwesterheim systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT edwardchsiao systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT jayminupadhyay systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT lucasangiorgi systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT alexanderartyomenko systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT kimcroskery systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT julietjohns systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT emmawarnants systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases
AT gaborbarton systematicliteraturereviewoftheimpactandmeasurementofmobilityimpairmentinrarebonediseases